MUC1 and familial pancreatic carcinoma: Furthermore, as recently shown in murine pancreatic cancer cell lines MUC1 is a potential therapeutic target (8) with small molecules in early clinical development, stimulating the characterization of a potential target population in pancreatic cancer (9).